MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SC5003-control    
Morpholino sequence: CCCAAATAACCCACTGACTGATACC
Find in Genbank
Target name: AI883960
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
GCCAGTCGGCTGGACAGACACAAGAGGAGCTTTTCGCGGGTTTATTGGGTGACTGACTATGGCAAGCCG GTCCAACTGTTTTTACTGTCGTGAGGACCTCAGTGGAAAGAAGTTCGTGAGGAAAGACGAGAAACAAGTC TGTGTGCGATGCTTCGACAAGTTCTGCGCAAACACCTGCACAGAGTGTCGACGCACGATCAGCACGGACT CCAAGGAGCTTCACCATAAGGGGAAATACTGGCACTCTGATTGTTTCCGATGTGCCAAGTGCTATAAGAA TCTGGCCAAGGAGTCTTTCACCTCCAAAGATGACAGGATCCTGTGTGGGACGTGTAGCTCACGTGAGGAC GCTCCTCGCTGCCATGGCTGCTACAAGCCCATACTGCCAGGCACTGAGAATGTGGAATACAAAGGCAACT CATGGCACGATGAGTGTTTCAAATGCTATCAGTGTCAAAAGCCAATCGGCAACAAGAGTTTCATAACAAA GAACAACAATGTCTACTGCAGCCCTTGCCATGAGAAGAAATTTGCCAAACAGTGTGCTTGCTGTAAGAAG CCCATTACCACAGGAGGTGTGAATTACCAGGACCAGCCGTGGCATTCAGAGTGCTTTGTGTGCTCCTCCT GCCGAAAGCCTCTGGCGGGCACCCGCTTTACCTCCCACGAGGAGAAAGTCTACTGTGTGGACTGCTATAA AAGCACTGTGGCCAAAAAATGCAGCGGTTGCCAGAACCCCATTACAGGATTTGGCAAGGCTACGAATGTA GTGAACTACGAGGGTGGCTCTTGGCATGATTACTGCTTCAACTGTAAGAAATGCTCCCTCAACCTGGCCG ACAAGCGCTTTGTTGCTCACAGCGGACACATTTACTGCTCCGACTGCTCCAAGAAACTGTAAACACTCAG AAGAGGGAGATTACTTTAGAAAAATATCAGCCTTCTTTTGAATTTATACAAAAATCCCACATAAAAATGT TGAAGTATTGACAAAGGCTTCTGTTGTGTTGATTCTGGCAGCTTTTTGAGGGGAGTTTGATGTTTCCTGT GAGGAATGTTTCGTTTACCTTGAGGCTTTGATAGGAAAACTTATCCTCTCTTTTTCCAATGACCCATTTG TCTCAGGAAAGATAGTAGGGCGGGAAGAAAGACAGATAGTAAAATAAGTGTTTTTGAGAATGTGAAGCCT GTTTTTGAGATGTATTGATCTTTCATTTCACATTTCATGATGCCAAATAAAGCTTTGGGTTGGTAACTTT TAGCCTATAATCATGACCAATGAATATTTCAGTGATTCAGCAAATTCCTTTCAAGATACTTTCATATAAA ATACCATACTGGAAAATTAAAGTGTGTAGGTTTTGTCTGTCTCCTTACTTATACGTTATCGTTAATGCAA TTAACATGAATAATCCATTTTCATTTCTTTGTATAAACTGAAAAATAAAGTTAAGTATCTGAGAAATCTG AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Gene targeted:
AI883960
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Blood: (12)
PAX2: (1)
Eye: (3)
- eye absent
(33.33%, dose:4.5ng, p53:ng, days: Day: 3)
- eye dysplastic
(11.11%, dose:4.5ng, p53:ng, days: Day: 3)
- eye small size
(44.44%, dose:4.5ng, p53:ng, days: Day: 3)

Images